FORM OF WARRANTBiocryst Pharmaceuticals Inc • August 7th, 2007 • Biological products, (no disgnostic substances) • New York
THIS CERTIFIES THAT, for value received, or registered assigns (the “Registered Holder”) is entitled to, upon the terms and conditions hereinafter set forth, subscribe for and purchase at the Exercise Price (defined below) from BioCryst Pharmaceuticals, Inc., a Delaware corporation (the “Company”), fully paid and nonassessable shares (the “Warrant Shares”) of Common Stock, $0.01 par value (the “Common Stock”), of the Company, at the initial exercise price of $10.25 per Warrant Share (the “Exercise Price”) at any time during the period beginning after the date hereof and ending on the Expiration Date (as hereinafter defined) (the “Exercise Period”), by surrendering this Warrant, with the Form of Election to Purchase duly executed at the principal office of the Company and by paying in full the Exercise Price, plus transfer taxes, if any. The term “Warrant” as used herein shall include this Warrant, and any warrant delivered in substitution or exchange for this Warrant as provided herein
STOCK AND WARRANT PURCHASE AGREEMENTStock and Warrant Purchase Agreement • August 7th, 2007 • Biocryst Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Stock and Warrant Purchase Agreement (the “Agreement”) is made this 6th day of August, 2007 between BioCryst Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of the Investors identified on the signature pages hereto (the “Investors”).
